These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7548775)

  • 1. Mean residence time of drugs administered non-instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non-linear elimination from the central compartment.
    Cheng H
    Biopharm Drug Dispos; 1995 May; 16(4):259-67. PubMed ID: 7548775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.
    Cheng H; Jusko WJ
    Pharm Res; 1993 Jan; 10(1):8-13. PubMed ID: 8430064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.
    Cheng H; Jusko WJ
    Pharm Res; 1990 Jun; 7(6):628-32. PubMed ID: 2367330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of mean residence-time concepts to pharmacokinetic systems with noninstantaneous input and nonlinear elimination.
    Cheng HY; Jusko WJ
    Pharm Res; 1989 Jan; 6(1):4-12. PubMed ID: 2717515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model.
    Kong AN; Jusko WJ
    J Pharm Sci; 1988 Feb; 77(2):157-65. PubMed ID: 3361431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ratio of first to zeroth moments of the plasma profile of an oral drug undergoing first-pass and linear reversible metabolism.
    Cheng H
    Biopharm Drug Dispos; 1995 Dec; 16(9):791-6. PubMed ID: 8580402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean interconversion times and distribution rate parameters for drugs undergoing reversible metabolism.
    Cheng HY; Jusko WJ
    Pharm Res; 1990 Oct; 7(10):1003-10. PubMed ID: 2281028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Types of mean residence times.
    Wagner JG
    Biopharm Drug Dispos; 1988; 9(1):41-57. PubMed ID: 3342284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.
    Berezhkovskiy LM
    Xenobiotica; 2016; 46(6):477-82. PubMed ID: 26406808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of Laplace transform for the general disposition deconvolution equation in drug metabolism kinetics.
    Popović J
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):409-11. PubMed ID: 10445406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmental mean residence time in a mammillary model with an effect compartment after intravenous or oral administration.
    Plusquellec Y; Houin G
    J Biomed Eng; 1990 Nov; 12(6):523-6. PubMed ID: 2266749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mean residence time concepts for pharmacokinetic systems with nonlinear drug elimination described by the Michaelis-Menten equation.
    Cheng HY; Jusko WJ
    Pharm Res; 1988 Mar; 5(3):156-64. PubMed ID: 3244627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Feb; 93(2):364-74. PubMed ID: 14705193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for calculating the mean absorption time of drugs undergoing reversible and first-pass metabolism.
    Cheng H; Shum L
    Biopharm Drug Dispos; 1993 Jan; 14(1):71-9. PubMed ID: 8427946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between drug input and mean residence time in the body.
    Bialer M; Look ZM; Silber BM; Yacobi A
    Biopharm Drug Dispos; 1986; 7(6):577-83. PubMed ID: 3828487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Jun; 93(6):1628-40. PubMed ID: 15124219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general model of metabolite kinetics following intravenous and oral administration of the parent drug.
    Weiss M
    Biopharm Drug Dispos; 1988; 9(2):159-76. PubMed ID: 3370305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.